Newtyn Management
Investment Details
Investor Type
Hedge Fund
Asset Class Focus
Equity Securities, Special Situations, Capital Structure Arbitrage
Stage Focus
Pre-IPO, Buyout, Turnaround, Distressed
Geographical Focus
United States
Industries Focus
- Financial Services
- Technology
- Healthcare
- Energy
- Consumer Goods
- Real Estate
- Materials
- Telecommunications
- Utilities
- Media
- Retail
- Transportation
- Pharmaceuticals
- Biotechnology
- Industrial Goods
Investment Size:
1,000,000 to 50,000,000 USD
Investor Details Founded: 2011
Newtyn Management is a value-oriented hedge fund founded in 2011, focusing on generating above-average risk-adjusted returns while maintaining low net exposure to overall financial market performance. The firm primarily invests in U.S. equity securities but has the expertise and flexibility to capitalize on opportunities across the capital structure, regardless of jurisdiction. Newtyn employs a rigorous, bottom-up investment approach, coupled with vigilant risk management and patience during periods of scarce opportunity.
The firm's investment strategy centers on identifying undervalued opportunities and special situations, such as corporate restructurings, bankruptcies, liquidations, mergers, acquisitions, divestitures, and new public offerings. Newtyn's portfolio is diversified across various sectors, including healthcare, biotechnology, pharmaceuticals, technology, consumer goods, retail, energy, utilities, telecommunications, media, financial services, real estate, transportation, industrial goods, and materials.
Newtyn Management's track record demonstrates a commitment to disciplined investing and a focus on generating superior returns for its investors. The firm's patient and strategic approach has enabled it to navigate complex market environments and capitalize on unique investment opportunities, solidifying its reputation in the hedge fund industry.
Requirements
- Accredited investors only
- Long-term investment horizon
Contact
[Official Website Hidden]
[HQ Location Hidden]
[Email Hidden]
[Contact Number Hidden]
Portfolio Companies
- Theravance Biopharma Inc
- 1-800-Flowers.com Inc
- QuidelOrtho Corp
- PAR Technology Corp
- IAC Inc
Claim this Investor
Are you an official representative of Newtyn Management?
Claim this investor to update information, manage your profile, and get a verified seal.
Claim